Danish Food Stock News

Celebrations may be in order for AL Sydbank A/S ( CPH:ALSYDB ) shareholders, with the analysts delivering a significant...

When close to half the companies in Denmark have price-to-earnings ratios (or "P/E's") above 15x, you may consider ISS...

Earlier in 2025, ROCKWOOL A/S launched a share buy-back programme running from 7 February 2025 to 5 February 2026, authorising repurchases of up to €150 million and bringing its holding to 4,364,356 B shares, or 2.06% of total share capital. This sizeable, year-long repurchase plan highlights management’s commitment to returning capital to investors and adjusting the company’s share count over time. Now, we’ll examine how this sizeable buy-back programme interacts with Rockwool’s existing...

On 5 February 2025, Pandora announced a new share buyback programme, appointing Danske Bank as sole lead manager for a tranche running until 30 January 2026, with the dual aim of reducing share capital and meeting obligations under company incentive schemes. This renewed focus on returning capital while supporting employee incentives adds a capital-allocation angle to Pandora's brand and margin-focused transformation story. We’ll now examine how Pandora’s decision to shrink its share capital...

Zealand Pharma (CPSE:ZEAL) just doubled down on its obesity and metabolic health ambitions by unveiling its Metabolic Frontier 2030 roadmap alongside a new multi program collaboration with OTR Therapeutics on next generation metabolic drugs. See our latest analysis for Zealand Pharma. Those moves land against a backdrop where the share price has climbed roughly 25% over the last three months but still sits well below earlier levels, and the three year total shareholder return above 150%...

In recent months, DSV has expanded its electric truck fleet through a Volvo Trucks partnership in South Africa, completed the integration and go-live of its Dubai operations after absorbing Schenker, and participated as a Global Partner at the inaugural Automotive Logistics & Supply Chain ASEAN conference in Singapore to deepen its role in regional automotive supply chains. Together, these developments show DSV pushing harder into lower-emission transport, strengthening its Middle East...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Brd. Klee fair value estimate is kr.3,566 Current share price...

Earlier this month, Novo Nordisk presented topline phase 3 Evoke and Evoke+ results for oral semaglutide in Alzheimer’s disease, showing statistically significant but clinically modest biomarker reductions and no success on the primary endpoints, while also completing its US$5.20 billion acquisition of Akero Therapeutics and advancing multiple obesity-drug initiatives. Although the Alzheimer’s data fell short clinically, the biomarker insights, expanding obesity pipeline, and new...

In recent months, Scandinavian Tobacco Group reported that its Signature Action cigarillo brand has almost doubled sales, added a new Signature Action Mix variant, and introduced larger 17-pack formats to appeal to value-focused smokers. The company has also moved into the nicotine pouch market with its XQS brand, which has quickly become the sixth-largest pouch label, signalling a meaningful broadening of its product portfolio beyond traditional tobacco. Next, we’ll examine how the rapid...

ALK-Abelló has announced that Edward Jordan, a biopharmaceutical executive with more than 30 years of experience, will become Executive Vice President and head of Commercial Operations in North America from January 2026, following the earlier elevation of the region into the Executive Leadership Team to support the Allergy+ strategy. By bringing in a leader with deep allergy and immunology expertise and a history of building US therapeutic markets, ALK-Abelló is clearly prioritizing stronger...

Earlier this month, Genmab A/S completed a US$1.50 billion offering of 6.250% senior secured notes due 2032 and US$1.00 billion of 7.250% senior unsecured notes due 2033 to help finance its pending acquisition of Merus N.V., alongside new term loans and a revolving credit facility. The combination of large-scale debt financing and strong epcoritamab and EPKINLY clinical data across several lymphoma studies highlights how Genmab is using both capital structure and science to expand its...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...

A.P. Møller - Mærsk has launched the second phase of its share buy-back program, planning to repurchase up to DKK 7.2 billion of shares between 11 August 2025 and 4 February 2026, bringing total buy-backs under the current program to as much as DKK 14.4 billion and lifting treasury holdings to 6.90% of share capital. This sizeable buy-back signals management’s confidence in capital allocation discipline and amplifies the impact of any future earnings through a shrinking share base. We’ll now...

With its stock down 11% over the past month, it is easy to disregard FLSmidth (CPH:FLS). However, stock prices are...

Pandora A/S ( CPH:PNDORA ), is not the largest company out there, but it saw significant share price movement during...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

As European markets continue to show resilience, with major indices like the STOXX Europe 600 and Germany’s DAX posting notable gains, investors are keenly observing economic indicators such as inflation trends that suggest stability around the ECB's target. In this environment, identifying stocks that may be undervalued can offer potential opportunities for growth, especially when these companies demonstrate strong fundamentals and a capacity to thrive amid evolving market conditions.

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

TCM Group A/S ( CPH:TCM ) just reported some strong earnings, and the market reacted accordingly with a healthy uplift...

NKT A/S' ( CPH:NKT ) price-to-earnings (or "P/E") ratio of 25x might make it look like a strong sell right now compared...

Dampskibsselskabet Norden A/S' ( CPH:DNORD ) price-to-earnings (or "P/E") ratio of 8.4x might make it look like a buy...

Coloplast A/S ( CPH:COLO B ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is commonly two...

The Shape Robotics A/S ( CPH:SHAPE ) share price has fared very poorly over the last month, falling by a substantial...